This Week’s Biopharma News: Big Moves in Bispecifics - Top-Institutions - MDSpire

This Week’s Biopharma News: Big Moves in Bispecifics

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

June 9, 2026
5 min

The Medicine Maker

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Harvard Medical School

Boston, MA
Key Differentiators
- Hematology
#2

City of Hope

Duarte, CA
Key Differentiators
- Hematology
- Oncology
#3

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology
- Oncology
#4

The Ohio State University Comprehensive Cancer Center

Columbus, OH
Key Differentiators
- Hematology
- Oncology